Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia

Neuropsychopharmacology

Volumn 23, Issue 4, 2000, Pages 351-364

  Breese, Charles R ^a,d   Lee, Michael J ^a   Adams, Cathy E ^a   Sullivan, Bernadette ^a   Logel, Judy ^b   Gillen, Kieron M ^a   Marks, Michael J ^c   Collins, Allan C ^c   Leonard, Sherry ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d AUBURN UNIVERSITY   (United States)

Author keywords

Cigarettes; Human brain; Nicotine; Nicotinic receptors; Postmortem; Receptor binding; Schizophrenia; Smoking

Indexed keywords

EPIBATIDINE; HALOPERIDOL; METHYLLYCACONITINE; NICOTINE; NICOTINIC RECEPTOR;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN CORTEX; CAUDATE NUCLEUS; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SCHIZOPHRENIA; SCHOOL CHILD; TISSUE DISTRIBUTION; TOBACCO;

ACONITINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; CHILD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PYRIDINES; RATS; RECEPTORS, NICOTINIC; REGRESSION ANALYSIS; SCHIZOPHRENIA; SMOKING;

EID: 0033832470     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00121-4     Document Type: Article

References (77)

1. Adler L.E., Hoffer L.D., Griffith J., Waldo M.C., Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 32:1992;607-616.
2. Adler L.E., Hoffer L.D., Wiser A., Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 150:1993;1856-1861.
3. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 24:1998;189-202.
4. Albuquerque E.X., Pereira E.F.R., Braga M.F.M. A basal α4β2 nicotinic receptor (nAChR) activity controls the release of GABA from hippocampal neurons. Soc Neurosci Abstr. 24:1998;1581.
5. Alkondon M., Pereira E.F.R., Barbosa C.T., Albuquerque E.X. Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharm Exp Ther. 283:1997;1396-1411.
6. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J Neurochem. 51:1988;292-299.
7. Baenziger J.E., Chew J.P. Desensitization of the nicotinic acetylcholine receptor mainly involves a structural change in solvent-accessible regions of the polypeptide backbone. Biochemistry. 36:1997;3617-3624.
8. 3H]nicotine binding sites in human brain. J Neurochem. 50:1988;1243-1247.
9. Bertolino M., Kellar K.J., Vicini S., Gillis R.A. Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience. 79:1997;671-681.
10. Blaha C.D., Allen L.F., Das S., Inglis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleusles-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci. 16:1996;714-722.
11. Bowman W.C., Marshall I.G., Gibb A.J., Harborne A.J. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol Sci. 9:1988;16-20.
12. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther. 282:1997;7-13. a.
13. Breese C.R., Adams C., Logel J., Drebing C., Rollins Y., Barnhart M., Sullivan B., Demasters B.K., Freedman R., Leonard S. Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [1251]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol. 387:1997;385-398. b.
14. Court J.A., Lloyd S., Thomas N., Piggott M.A., Marshall E.F., Morris C.M., Lamb H., Perry R.H., Johnson M., Perry E.K. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience. 87:1998;63-78.
15. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia. Clinical phenomena and laboratory findings Am J Psychiatry. 155:1998;1490-1501.
16. Davies A.R., Hardick D.J., Blagbrough I.S., Potter B.V., Wolstenholme A.J., Wonnacott S. Characterization of the binding of [3H]methyllycaconitine. A new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors Neuropharmacology. 38:1999;679-690.
17. de Leon J., Dadvand M., Canuso C., White A.O., Stanilia J.K., Simpson G.M. Schizophrenia and smoking. An epidemiological survey in a state hospital Am J Psychiatry. 152:1995;453-455.
18. Decina P., Caracci G., Sandik R., Berman W., Mukherjee S., Scapicchio P. Cigarette smoking and neuroleptic-induced parkinsonism. Biol Psychiatry. 28:1990;502-508.
19. Eilers H., Schaeffer E., Bickler P.E., Forsayeth J.R. Functional deactivation of the major neuronal nicotinic receptor caused by nicotine and a protein kinase C-dependent mechanism. Mol Pharmacol. 52:1997;1105-1112.
20. Fenster C.P., Whitworth T.L., Sheffield E.B., Quick M.W., Lester R.A. Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine. J Neurosci. 19:1999;4804-4814.
21. Flores C.M., Davila-Garcia M.I., Ulrich Y.M., Kellar K.J. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem. 69:1997;2216-2219.
22. Freedman R., Coon H., Myles-Worsley M., Orr-Urtreger A., Olincy A., Davis A., Polymeropoulos M., Holik J., Hopkins J., Hoff M., Rosenthal J., Waldo M.C., Reimherr F., Wender P., Yaw J., Young D.A., Breese C.R., Adams C., Patterson D., Adler L.E., Kruglyak L., Leonard S., Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 94:1997;587-592.
23. Freedman R., Hall M., Adler L.E., Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 38:1995;22-33.
24. George T.P., Sernyak M.J., Ziedonis D.M., Woods S.W. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 56:1995;344-346.
25. Goff D.C., Henderson D.C., Amico E. Cigarette smoking in schizophrenia. Relationship to psychopathology and medication side effects Am J Psychiatry. 149:1992;1189-1194.
26. Goldstein G., Allen D.N., van Kammen D.P. Individual differences in cognitive decline in schizophrenia. Am J Psychiatry. 155:1998;1117-1118.
27. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem. 62:1994;1390-1398.
28. Grenhoff J., Svensson T.H. Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol Scand. 133:1988;595-596.
29. Heinrichs R.W., Zakzanis K.K. Neurocognitive deficit in schizophrenia. A quantitative review of the evidence Neuropsychology. 12:1998;426-445.
30. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol. 48:1995;280-287.
31. Hsu Y.N., Edwards S.C., Wecker L. Nicotine enhances the cyclic AMP-dependent protein kinase-mediated phosphorylation of α4 subunits of neuronal nicotinic receptors. J Neurochem. 69:1997;2427-2431.
32. Hyde T.M., Nawroz S., Goldberg T.E., Bigelow L.B., Strong D., Ostrem J.L., Weinberger D.R., Kleinman J.E. Is there cognitive decline in schizophrenia? A cross-sectional study. Br J Psychiatry. 164:1994;494-500.
33. Jann M.W., Saklad S.R., Ereshefsky L., Richards A.L., Harrington C.A., Davis C.M. Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance. Psychopharmacology. 90:1986;468-470.
34. Kaufmann C.A., Suarez B., Malaspina D., Pepple J., Svrakic D., Markel P.D., Meyer J., Zambuto C.T., Schmitt K., Matise T.C., Harkavy F.J., Hampe C., Lee H., Shore D., Wynne D., Faraone S.V., Tsuang M.T., Cloninger C.R. NIMH Genetics Initiative Millenium Schizophrenia Consortium. Linkage analysis of African-American pedigrees Am J Med Genet. 81:1998;282-289.
35. Keppel G. Design and Analysis. A Researcher's Handbook 3rd ed:1991;Prentice-Hall, Inc, Englewood Cliffs, NJ.
36. Lee M.J., Breese C.R., Leonard S. The effect of nicotine and haloperidol on high affinity nicotinic receptors and dopamine D2 receptors in the rat brain. J Neurosci. 24:1998;833.
37. Leonard S., Adams C., Breese C.R., Adler L.E., Bickford P., Byerley W., Coon H., Griffith J.M., Miller C., Myles-Worsley M., Nagamoto H.T., Rollins Y., Stevens K.E., Waldo M., Freedman R. Nicotinic receptor function in schizophrenia. Schizophr Bull. 22:1996;431-445.
38. Leonard S., Adler L.E., Olincy A., Breese C.R., Gault J., Ross R.G., Lee M., Cawthra E., Nagamoto H.T., Freedman R. The role of nicotine and nicotinic receptors in psychopathology. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptor. Pharmacology and Therapeutic Opportunities:1998;307-321 Wiley-Liss, Inc, New York. a.
39. Leonard S., Gault J., Moore T., Hopkins J., Robinson M., Olincy A., Adler L.E., Cloninger C.R., Kaufmann C.A., Tsuang M.T., Faraone S.V., Malaspina D., Svrakic D.M., Freedman R. Further investigation of a chromosome 15 locus in schizophrenia. Analysis of affected sibpairs from the NIMH Genetics Initiative Am J Med Genet. 81:1998;308-312. b.
40. Leonard S., Logel J., Luthman D., Casanova M., Kirch D., Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry. 33:1993;456-466.
41. Liang S.D., Vizi E.S. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion. J Pharmacol Exp Ther. 280:1997;650-655.
42. Lohr J.B., Flynn K. Smoking and schizophrenia. Schizophr Res. 8:1992;93-102.
43. Luntz-Leybman V., Bickford P.C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
44. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci. 22:1999;443-485.
45. Marks M.J., Collins A.C. Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol. 22:1982;554-564.
46. Marks M.J., Stitzel J.A., Collins A.C. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther. 235:1985;619-628.
47. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., Collins A.C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci. 12:1992;2765-2784.
48. Marks M.J., Smith K.W., Collins A.C. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. J Pharmacol Exp Ther. 285:1998;377-386.
49. McEvoy J.P., Freudenreich O., Levin E.D., Rose J.E. Haloperidol increases smoking in patients with schizophrenia. Psychopharmacology. 119:1995;124-126.
50. Miller D.D., Kelly M.W., Perry P.J., Coryell W.H. The influence of cigarette smoking on haloperidol pharmacokinetics. Biol Psychiatry. 28:1990;529-531.
51. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K.A., Freedman R. Gating of auditory P50 in schizophrenics. Unique effects of clozapine Biol Psychiatry. 40:1996;181-188.
52. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos. 24:1996;1212-1217.
53. Olincy A., Young D.A., Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry. 42:1997;1-5.
54. Olincy A., Ross R.G., Young D.A., Roath M., Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology. 18:1998;175-185.
55. Peng X., Gerzanich V., Anand R., Whiting P.J., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol. 46:1994;523-530.
56. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
57. 3H] dopamine release from striatal synaptosomes. pharmacological characterization J Neurochem. 54:1990;937-945.
58. Riley B.P., Makoff A.M., Mogudi-Carter M., Jenkins T.J., Williamson R., Collier D.A., Murray R.M. High marker-density analyses of the α7-nicotinic cholinergic receptor subunit (CHRNA7) gene region on chromosome 15q13-q14 and 5′ RACE cloning of fragments specific to CHRNA7 or its partial duplication. Schizophr Res. 41:2000;93.
59. Romm E., Lippiello P.M., Marks M.J., Collins A.C. Purification of L-[3H]nicotine eliminates low affinity binding. Life Sci. 46:1990;935-943.
60. 3H]dopamine from rat striatal synaptosomes. Neurosci Lett. 189:1995;171-175.
61. 3H]acetylcholine release from mouse cerebral cortical synaptosomes. J Neurochem. 43:1984;1593-1598.
62. Sandyk R. Cigarette smoking. effects on cognitive functions and drug-induced parkinsonism in chronic schizophrenia Int J Neurosci. 70:1993;193-197.
63. Sershen H., Toth E., Lajtha A., Vizi E.S. Nicotine effects on presynaptic receptor interactions. Ann NY Acad Sci. 757:1995;238-244.
64. Stevens K.E., Freedman R., Collins A.C., Hall M., Leonard S., Marks M.J., Rose G.M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Brain Res. 15:1996;152-162.
65. Stevens K.E., Kem W.R., Mahnir V.M., Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 136:1998;320-327.
66. Summers K.L., Giacobini E. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochem Res. 20:1995;753-759.
67. Summers K.L., Kem W.R., Giacobini E. Nicotinic agonist modulation of neurotransmitter levels in the rat frontoparietal cortex. Jap J Pharmacol. 74:1997;139-146.
68. Takahashi H., Takada Y., Nagai N., Urano T., Takada A. Nicotine increases stress-induced serotonin release by stimulating nicotinic acetylcholine receptor in rat striatum. Synapse. 28:1998;212-219.
69. Tian L., Prior C., Dempster J., Marshall I.G. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J Physiol. 476:1994;517-529.
70. Ulrich Y.M., Hargreaves K.M., Flores C.M. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites. Neuropharmacology. 36:1997;1119-1125.
71. Vibat C.R., Lasalde J.A., McNamee M.G., Ochoa E.L. Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus laevis oocytes. Cell Mol Neurobiol. 15:1995;411-425.
72. Ward J.M., Cockcroft V.B., Lunt G.G., Smillie F.S., Wonnacott S. Methyllycaconitine. A selective probe for neuronal alpha-bungarotoxin binding sites FEBS Lett. 270:1990;45-48.
73. Wilkie G.I., Hutson P., Sullivan J.P., Wonnacoft S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem Res. 21:1996;1141-1148.
74. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
75. Xiao Y., Meyer E.L., Thompson J.M., Surin A., Wroblewski J., Kellar K.J. Rat α3/β4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line. Pharmacology of ligand binding and function Mol Pharmacol. 54:1998;322-333.
76. Yang X., Criswell H.E., Breese G.R. Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther. 276:1996;482-489.
77. Ziedonis D.M., Kosten T.R., Glazer W.M., Frances R.J. Nicotine dependence and schizophrenia. Hosp Commun Psychiatry. 45:1994;204-206.